{"id":18553,"date":"2026-05-15T21:11:00","date_gmt":"2026-05-15T21:11:00","guid":{"rendered":"https:\/\/uaenewsroom.com\/2-1-billion-by-2035-how-next-generation-sequencing-and-liquid-biopsy-are-transforming-precision-medicine\/"},"modified":"2026-05-15T21:11:00","modified_gmt":"2026-05-15T21:11:00","slug":"2-1-billion-by-2035-how-next-generation-sequencing-and-liquid-biopsy-are-transforming-precision-medicine","status":"publish","type":"post","link":"https:\/\/uaenewsroom.com\/en\/2-1-billion-by-2035-how-next-generation-sequencing-and-liquid-biopsy-are-transforming-precision-medicine\/","title":{"rendered":"$2.1 Billion by 2035 \u2014 How Next-Generation Sequencing and Liquid Biopsy Are Transforming Precision Medicine"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div class=\"content-inner \">\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">MiRNA Sequencing | Assay Market | Liquid Biopsy | Regional Breakdown | April 2026 | Source: Market Research<\/span><\/strong><\/p>\n<hr>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"katex\"><span class=\"katex-mathml\">2.1B\u2217\u2217\u2223\u2217\u221712.5<\/span><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord\">2.1<\/span><span class=\"mord mathnormal\">B<\/span><span class=\"mbin\">\u2217<\/span><\/span><span class=\"base\"><span class=\"mord\">\u2217<\/span><span class=\"mord\">\u2223<\/span><span class=\"mbin\">\u2217<\/span><\/span><span class=\"base\"><span class=\"mord\">\u2217<\/span><span class=\"mord\">12.5<\/span><\/span><\/span><\/span><span class=\"\">0.65B<\/span><\/strong><br \/>\n<span class=\"\">Market Value by 2035 | CAGR (2026-2035) | Market Value in 2025<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">MiRNA Sequencing Assay Market<\/span><\/strong><\/p>\n<hr>\n<h3><span class=\"\">Key Takeaways<\/span><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">MiRNA Sequencing Assay Market is projected to reach USD 2.1 billion by 2035 at a 12.5% CAGR .<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Next-generation sequencing (NGS) dominates the technology segment; real-time PCR (qPCR) is the fastest-growing .<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Oncology and cancer research applications lead market demand; cardiovascular and neurological diseases are rapidly growing .<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad lead the competitive landscape .<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">North America holds the largest market share; Asia-Pacific is the fastest-growing region .<\/span><\/p>\n<\/li>\n<\/ul>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">The\u00a0<\/span><strong><a href=\"https:\/\/www.wiseguyreports.com\/reports\/mirna-sequencing-assay-market\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"\">MiRNA Sequencing Assay Market<\/span><\/a><\/strong><span class=\"\">\u00a0is projected to grow from USD 0.65 billion in 2025 to USD 2.1 billion by 2035 at a 12.5% CAGR , driven by increasing prevalence of cancer and chronic diseases, growing demand for liquid biopsy-based diagnostics, and the adoption of\u00a0<\/span><strong><a href=\"https:\/\/www.wiseguyreports.com\/reports\/mirna-sequencing-assay-market\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"\">MiRNA Sequencing<\/span><\/a><\/strong><span class=\"\">\u00a0and\u00a0<\/span><strong><a href=\"https:\/\/www.wiseguyreports.com\/reports\/mirna-sequencing-assay-market\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"\">Liquid Biopsy<\/span><\/a><\/strong><span class=\"\">\u00a0technologies that enable non-invasive disease detection, early diagnosis, and personalized treatment monitoring across oncology, cardiovascular, and neurological applications worldwide .<\/span><\/p>\n<h3><span class=\"\">Market Size and Forecast (2025-2035)<\/span><\/h3>\n<div class=\"ds-scroll-area ds-scroll-area--show-on-focus-within _1210dd7 c03cafe9\">\n<div class=\"ds-scroll-area__gutters\">\n<div class=\"ds-scroll-area__horizontal-gutter\"><\/div>\n<div class=\"ds-scroll-area__vertical-gutter\"><\/div>\n<\/div>\n<table>\n<thead>\n<tr>\n<th><span class=\"\">Metric<\/span><\/th>\n<th><span class=\"\">2025 Value<\/span><\/th>\n<th><span class=\"\">2035 Projected Value \/ CAGR<\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span class=\"\">MiRNA Sequencing Assay Market<\/span><\/td>\n<td><span class=\"\">USD 0.65B<\/span><\/td>\n<td><span class=\"\">USD 2.1B | 12.5% CAGR<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">*Source: Market Research Future *<\/span><\/p>\n<h3><span class=\"\">Segment &amp; Technology Breakdown<\/span><\/h3>\n<div class=\"ds-scroll-area ds-scroll-area--show-on-focus-within _1210dd7 c03cafe9\">\n<div class=\"ds-scroll-area__gutters\">\n<div class=\"ds-scroll-area__horizontal-gutter\"><\/div>\n<div class=\"ds-scroll-area__vertical-gutter\"><\/div>\n<\/div>\n<table>\n<thead>\n<tr>\n<th><span class=\"\">Product Type<\/span><\/th>\n<th><span class=\"\">Segment<\/span><\/th>\n<th><span class=\"\">Primary Buyer<\/span><\/th>\n<th><span class=\"\">Key Driver<\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span class=\"\">Instruments<\/span><\/td>\n<td><span class=\"\">NGS Systems<\/span><\/td>\n<td><span class=\"\">Research Labs<\/span><\/td>\n<td><span class=\"\">High-throughput<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Consumables<\/span><\/td>\n<td><span class=\"\">Kits, Reagents<\/span><\/td>\n<td><span class=\"\">Diagnostic Centers<\/span><\/td>\n<td><span class=\"\">Recurring revenue<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Services<\/span><\/td>\n<td><span class=\"\">Sequencing Services<\/span><\/td>\n<td><span class=\"\">Hospitals<\/span><\/td>\n<td><span class=\"\">Outsourced analysis<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"ds-scroll-area ds-scroll-area--show-on-focus-within _1210dd7 c03cafe9\">\n<div class=\"ds-scroll-area__gutters\">\n<div class=\"ds-scroll-area__horizontal-gutter\"><\/div>\n<div class=\"ds-scroll-area__vertical-gutter\"><\/div>\n<\/div>\n<table>\n<thead>\n<tr>\n<th><span class=\"\">Technology<\/span><\/th>\n<th><span class=\"\">Segment<\/span><\/th>\n<th><span class=\"\">Primary Buyer<\/span><\/th>\n<th><span class=\"\">Key Driver<\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span class=\"\">Next-Generation Sequencing<\/span><\/td>\n<td><span class=\"\">High Throughput<\/span><\/td>\n<td><span class=\"\">Genomic Centers<\/span><\/td>\n<td><span class=\"\">Comprehensive analysis<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Real-Time PCR (qPCR)<\/span><\/td>\n<td><span class=\"\">Targeted<\/span><\/td>\n<td><span class=\"\">Clinical Labs<\/span><\/td>\n<td><span class=\"\">Cost-effective<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Microarray<\/span><\/td>\n<td><span class=\"\">Expression Profiling<\/span><\/td>\n<td><span class=\"\">Research<\/span><\/td>\n<td><span class=\"\">Established method<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Digital PCR<\/span><\/td>\n<td><span class=\"\">Absolute Quantification<\/span><\/td>\n<td><span class=\"\">Precision Medicine<\/span><\/td>\n<td><span class=\"\">High sensitivity<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"ds-scroll-area ds-scroll-area--show-on-focus-within _1210dd7 c03cafe9\">\n<div class=\"ds-scroll-area__gutters\">\n<div class=\"ds-scroll-area__horizontal-gutter\"><\/div>\n<div class=\"ds-scroll-area__vertical-gutter\"><\/div>\n<\/div>\n<table>\n<thead>\n<tr>\n<th><span class=\"\">Application<\/span><\/th>\n<th><span class=\"\">Segment<\/span><\/th>\n<th><span class=\"\">Primary Buyer<\/span><\/th>\n<th><span class=\"\">Key Driver<\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span class=\"\">Cancer Research<\/span><\/td>\n<td><span class=\"\">Oncology<\/span><\/td>\n<td><span class=\"\">Research Institutes<\/span><\/td>\n<td><span class=\"\">Early detection<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Cardiovascular<\/span><\/td>\n<td><span class=\"\">Heart Disease<\/span><\/td>\n<td><span class=\"\">Hospitals<\/span><\/td>\n<td><span class=\"\">Biomarker discovery<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Neurological Disorders<\/span><\/td>\n<td><span class=\"\">Brain Research<\/span><\/td>\n<td><span class=\"\">Academic Centers<\/span><\/td>\n<td><span class=\"\">Disease monitoring<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Infectious Diseases<\/span><\/td>\n<td><span class=\"\">Pathogen Detection<\/span><\/td>\n<td><span class=\"\">Public Health<\/span><\/td>\n<td><span class=\"\">Rapid diagnosis<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Autoimmune Disorders<\/span><\/td>\n<td><span class=\"\">Immunology<\/span><\/td>\n<td><span class=\"\">Pharma R&amp;D<\/span><\/td>\n<td><span class=\"\">Drug response<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"ds-scroll-area ds-scroll-area--show-on-focus-within _1210dd7 c03cafe9\">\n<div class=\"ds-scroll-area__gutters\">\n<div class=\"ds-scroll-area__horizontal-gutter\"><\/div>\n<div class=\"ds-scroll-area__vertical-gutter\"><\/div>\n<\/div>\n<table>\n<thead>\n<tr>\n<th><span class=\"\">End User<\/span><\/th>\n<th><span class=\"\">Segment<\/span><\/th>\n<th><span class=\"\">Primary Buyer<\/span><\/th>\n<th><span class=\"\">Key Driver<\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span class=\"\">Pharmaceutical &amp; Biotech<\/span><\/td>\n<td><span class=\"\">Drug Discovery<\/span><\/td>\n<td><span class=\"\">Pharma Companies<\/span><\/td>\n<td><span class=\"\">Target identification<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Academic Research<\/span><\/td>\n<td><span class=\"\">Basic Science<\/span><\/td>\n<td><span class=\"\">Universities<\/span><\/td>\n<td><span class=\"\">Fundamental research<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Diagnostic Laboratories<\/span><\/td>\n<td><span class=\"\">Clinical Testing<\/span><\/td>\n<td><span class=\"\">Hospitals<\/span><\/td>\n<td><span class=\"\">Patient diagnosis<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">CROs<\/span><\/td>\n<td><span class=\"\">Outsourced Research<\/span><\/td>\n<td><span class=\"\">Biotech<\/span><\/td>\n<td><span class=\"\">R&amp;D support<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">*Source: Market Research Future *<\/span><\/p>\n<h3><span class=\"\">What Is Driving the MiRNA Sequencing Assay Market Demand?<\/span><\/h3>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Increasing Cancer Prevalence:<\/span><\/strong><span class=\"\">\u00a0The global cancer burden continues to rise, with approximately 19.3 million new cases and 10 million cancer deaths reported in 2020. MiRNA sequencing offers non-invasive liquid biopsy alternatives to traditional tissue biopsies, driving demand for early detection and monitoring tools .<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Advancements in Next-Generation Sequencing (NGS):<\/span><\/strong><span class=\"\">\u00a0NGS technologies have dramatically reduced sequencing costs from\u00a0<\/span><span class=\"katex\"><span class=\"katex-mathml\">100millionpergenomein2001tounder<\/span><span class=\"katex-html\" aria-hidden=\"true\"><span class=\"base\"><span class=\"mord\">100<\/span><span class=\"mord mathnormal\">mi<\/span><span class=\"mord mathnormal\">ll<\/span><span class=\"mord mathnormal\">i<\/span><span class=\"mord mathnormal\">o<\/span><span class=\"mord mathnormal\">n<\/span><span class=\"mord mathnormal\">p<\/span><span class=\"mord mathnormal\">er<\/span><span class=\"mord mathnormal\">g<\/span><span class=\"mord mathnormal\">e<\/span><span class=\"mord mathnormal\">n<\/span><span class=\"mord mathnormal\">o<\/span><span class=\"mord mathnormal\">m<\/span><span class=\"mord mathnormal\">e<\/span><span class=\"mord mathnormal\">in<\/span><span class=\"mord\">2001<\/span><span class=\"mord mathnormal\">t<\/span><span class=\"mord mathnormal\">o<\/span><span class=\"mord mathnormal\">u<\/span><span class=\"mord mathnormal\">n<\/span><span class=\"mord mathnormal\">d<\/span><span class=\"mord mathnormal\">er<\/span><\/span><\/span><\/span><span class=\"\">600 today. This cost reduction has made comprehensive miRNA profiling accessible to routine research and clinical applications .<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Growing Liquid Biopsy Adoption:<\/span><\/strong><span class=\"\">\u00a0Liquid biopsy market is projected to reach $8 billion by 2028. MiRNA biomarkers in blood, urine, and other body fluids enable non-invasive cancer detection, treatment monitoring, and recurrence surveillance without surgical biopsies .<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Rising Focus on Personalized Medicine:<\/span><\/strong><span class=\"\">\u00a0Healthcare systems are shifting from one-size-fits-all treatments to precision medicine approaches. MiRNA expression profiles predict drug response, disease progression, and patient outcomes, enabling tailored therapeutic strategies .<\/span><\/p>\n<blockquote>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">KEY INSIGHT<\/span><\/strong><\/p>\n<\/blockquote>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">|&gt; Next-Generation Sequencing (NGS) is the leading technology segment, offering high-throughput comprehensive profiling. Real-time PCR (qPCR) is the fastest-growing segment due to its cost-effectiveness and suitability for targeted validation studies. The consumables segment holds the largest market share, driven by recurring purchases of kits and reagents for miRNA isolation, library preparation, and detection .<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Get the full data \u2014 free sample available:<\/span><\/strong><\/p>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">\u2192\u00a0<\/span><strong><a href=\"https:\/\/www.wiseguyreports.com\/sample-request?id=698069\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"\">Download Free Sample PDF: MiRNA Sequencing Assay Market<\/span><\/a><\/strong><\/p>\n<p class=\"ds-markdown-paragraph\"><em><span class=\"\">Includes market sizing, segmentation methodology, and regional forecast tables.<\/span><\/em><\/p>\n<h3><span class=\"\">Regional Market Breakdown<\/span><\/h3>\n<div class=\"ds-scroll-area ds-scroll-area--show-on-focus-within _1210dd7 c03cafe9\">\n<div class=\"ds-scroll-area__gutters\">\n<div class=\"ds-scroll-area__horizontal-gutter\"><\/div>\n<div class=\"ds-scroll-area__vertical-gutter\"><\/div>\n<\/div>\n<table>\n<thead>\n<tr>\n<th><span class=\"\">Region<\/span><\/th>\n<th><span class=\"\">Maturity<\/span><\/th>\n<th><span class=\"\">Key Drivers<\/span><\/th>\n<th><span class=\"\">Outlook<\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span class=\"\">North America<\/span><\/td>\n<td><span class=\"\">Largest (42% share)<\/span><\/td>\n<td><span class=\"\">Strong R&amp;D funding, advanced healthcare infrastructure<\/span><\/td>\n<td><span class=\"\">Strong growth<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Europe<\/span><\/td>\n<td><span class=\"\">Mature<\/span><\/td>\n<td><span class=\"\">Research collaborations, biotech hubs<\/span><\/td>\n<td><span class=\"\">Steady growth<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Asia-Pacific<\/span><\/td>\n<td><span class=\"\">Fastest-Growing (15%+ CAGR)<\/span><\/td>\n<td><span class=\"\">Increasing research funding, clinical trial expansion<\/span><\/td>\n<td><span class=\"\">Highest growth<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Latin America<\/span><\/td>\n<td><span class=\"\">Emerging<\/span><\/td>\n<td><span class=\"\">Growing research capacity<\/span><\/td>\n<td><span class=\"\">Moderate growth<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Middle East &amp; Africa<\/span><\/td>\n<td><span class=\"\">Early Stage<\/span><\/td>\n<td><span class=\"\">Infrastructure development<\/span><\/td>\n<td><span class=\"\">Gradual growth<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">*Sources: Market Research Future *<\/span><\/p>\n<h3><span class=\"\">Competitive Landscape<\/span><\/h3>\n<div class=\"ds-scroll-area ds-scroll-area--show-on-focus-within _1210dd7 c03cafe9\">\n<div class=\"ds-scroll-area__gutters\">\n<div class=\"ds-scroll-area__horizontal-gutter\"><\/div>\n<div class=\"ds-scroll-area__vertical-gutter\"><\/div>\n<\/div>\n<table>\n<thead>\n<tr>\n<th><span class=\"\">Category<\/span><\/th>\n<th><span class=\"\">Key Players<\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span class=\"\">Sequencing Technology Leaders<\/span><\/td>\n<td><span class=\"\">Illumina, Thermo Fisher Scientific, Pacific Biosciences<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Consumables &amp; Kits<\/span><\/td>\n<td><span class=\"\">Qiagen, Agilent Technologies, Bio-Rad Laboratories<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">PCR Specialists<\/span><\/td>\n<td><span class=\"\">Roche Diagnostics, Takara Bio<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Emerging Innovators<\/span><\/td>\n<td><span class=\"\">NanoString Technologies, Exiqon (Qiagen), HTG Molecular<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">*Sources: Market Research Future *<\/span><\/p>\n<h3><span class=\"\">Outlook Through 2035<\/span><\/h3>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">The convergence of NGS cost reduction, liquid biopsy acceptance, and AI-powered data analysis will define the miRNA sequencing assay market through 2035. Key trends shaping the market include:<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Integration with Multi-Omics Approaches:<\/span><\/strong><span class=\"\">\u00a0miRNA sequencing increasingly integrated with genomics, proteomics, and metabolomics for comprehensive disease profiling, enabling systems biology understanding of complex diseases.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">AI-Powered Data Analysis:<\/span><\/strong><span class=\"\">\u00a0Machine learning algorithms identifying novel miRNA biomarkers from large datasets, reducing analysis time and improving prediction accuracy for disease diagnosis and prognosis.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Point-of-Care Applications:<\/span><\/strong><span class=\"\">\u00a0Development of rapid, low-cost miRNA detection platforms for decentralized testing, enabling early cancer screening in community healthcare settings.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Extracellular Vesicle (EV) miRNA Analysis:<\/span><\/strong><span class=\"\">\u00a0Growing focus on exosome-derived miRNAs as stable, non-invasive biomarkers for liquid biopsy applications, particularly in oncology and neurology.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Regulatory Approvals for Clinical Use:<\/span><\/strong><span class=\"\">\u00a0Increasing number of miRNA-based diagnostic assays receiving FDA and CE-IVD clearance, validating clinical utility and expanding market access.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Emerging Applications in Drug Development:<\/span><\/strong><span class=\"\">\u00a0Pharmaceutical companies incorporating miRNA biomarkers into clinical trials for patient stratification, target engagement monitoring, and pharmacodynamic response assessment.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Vendors investing in NGS innovation, AI-powered analytics, point-of-care platforms, and regulatory-approved clinical assays will capture the highest-margin contracts as miRNA sequencing evolves from research tool to essential component of precision medicine diagnostics.<\/span><\/p>\n<hr>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Access complete forecasts, segment analysis &amp; competitive intelligence:<\/span><\/strong><\/p>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">\u2192\u00a0<\/span><strong><a href=\"https:\/\/www.wiseguyreports.com\/reports\/mirna-sequencing-assay-market\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"\">Purchase the Full MiRNA Sequencing Assay Market Report (2025-2035)<\/span><\/a><\/strong><\/p>\n<p class=\"ds-markdown-paragraph\">*<span class=\"\">10-year forecasts | Segment &amp; application analysis | Regional data | Competitive landscape<\/span>*<\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Keywords:<\/span><\/strong><span class=\"\">\u00a0MiRNA Sequencing | Assay Market | Liquid Biopsy | NGS | miRNA Biomarker | Cancer Diagnostics | Precision Medicine | Small RNA<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">\u00a9 2026 WiseGuy Reports (WGR) \u00b7 All Rights Reserved \u00b7\u00a0<\/span><a href=\"https:\/\/wiseguyreports.com\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"\">wiseguyreports.com<\/span><\/a><\/p>\n<p class=\"ds-markdown-paragraph\"><em><span class=\"\">All market projections are forward-looking estimates sourced from WGR\u2019s proprietary research reports and subject to revision.<\/span><\/em><\/p>\n<\/p><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/marketpresswire.com\/mirna-sequencing-assay-market\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MiRNA Sequencing | Assay Market | Liquid Biopsy | Regional Breakdown | April 2026 | Source: Market Research 2.1B\u2217\u2217\u2223\u2217\u221712.52.1B\u2217\u2217\u2223\u2217\u221712.50.65B Market Value by 2035 | CAGR (2026-2035) | Market Value in 2025 MiRNA Sequencing Assay Market Key Takeaways MiRNA Sequencing Assay Market is projected to reach USD 2.1 billion by 2035 at a 12.5% CAGR . [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":18554,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[185,314],"tags":[2512,1572,5441,6777,6778],"class_list":["post-18553","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","category-314","tag-genomics","tag-biotechnology","tag-lifesciences","tag-moleculardiagnostics","tag-sequencingtechnology"],"_links":{"self":[{"href":"https:\/\/uaenewsroom.com\/en\/wp-json\/wp\/v2\/posts\/18553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/uaenewsroom.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/uaenewsroom.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/uaenewsroom.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/uaenewsroom.com\/en\/wp-json\/wp\/v2\/comments?post=18553"}],"version-history":[{"count":0,"href":"https:\/\/uaenewsroom.com\/en\/wp-json\/wp\/v2\/posts\/18553\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/uaenewsroom.com\/en\/wp-json\/wp\/v2\/media\/18554"}],"wp:attachment":[{"href":"https:\/\/uaenewsroom.com\/en\/wp-json\/wp\/v2\/media?parent=18553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/uaenewsroom.com\/en\/wp-json\/wp\/v2\/categories?post=18553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/uaenewsroom.com\/en\/wp-json\/wp\/v2\/tags?post=18553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}